Global Regenerative Therapies for Osteoarthritis Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Osteoarthritis is a type of joint disease that results from breakdown of joint cartilage and underlying bone.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Regenerative Therapies for Osteoarthritis estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The increasing incidence of osteoarthritis is expected to drive the regenerative therapies for osteoarthritis market.

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Regenerative Therapies for Osteoarthritis companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Regenerative Therapies for Osteoarthritis market. Further, it explains the major drivers and regional dynamics of the global Regenerative Therapies for Osteoarthritis market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Acelity

Mesoblast

Nuo Therapeutics

Astellas Pharma

Organovo

Orgenesis

Sanofi

Athersys

Takeda

Cytori Therapeutics

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Cell Therapy

Tissue Engineering

Gene Therapy

Hospitals

Ambulatory Surgical Centers

Orthopaedic Clinics

Research Institutes

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Regenerative Therapies for Osteoarthritis market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Regenerative Therapies for Osteoarthritis market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Regenerative Therapies for Osteoarthritis, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Regenerative Therapies for Osteoarthritis, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Regenerative Therapies for Osteoarthritis revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Regenerative Therapies for Osteoarthritis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Regenerative Therapies for Osteoarthritis revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Acelity, Mesoblast, Nuo Therapeutics, Astellas Pharma, Organovo, Orgenesis, Sanofi, Athersys and Takeda, etc.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Regenerative Therapies for Osteoarthritis Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Cell Therapy

1.2.3 Tissue Engineering

1.2.4 Gene Therapy

1.3 Market by Application

1.3.1 Global Regenerative Therapies for Osteoarthritis Market Growth Rate by Application: 2017 VS 2021 VS 2028

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Orthopaedic Clinics

1.3.5 Research Institutes

1.4 Study Objectives

1.5 Years Considered

2.1 Global Regenerative Therapies for Osteoarthritis Market Size (2017-2028)

2.2 Regenerative Therapies for Osteoarthritis Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028

2.3 Global Regenerative Therapies for Osteoarthritis Market Size by Region (2017-2022)

2.4 Global Regenerative Therapies for Osteoarthritis Market Size Forecast by Region (2023-2028)

2.5 Global Top Regenerative Therapies for Osteoarthritis Countries Ranking by Market Size

3.1 Global Regenerative Therapies for Osteoarthritis Revenue by Players

3.1.1 Global Regenerative Therapies for Osteoarthritis Revenue by Players (2017-2022)

3.1.2 Global Regenerative Therapies for Osteoarthritis Market Share by Players (2017-2022)

3.2 Global Regenerative Therapies for Osteoarthritis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Company Covered: Ranking by Regenerative Therapies for Osteoarthritis Revenue

3.4 Global Regenerative Therapies for Osteoarthritis Market Concentration Ratio

3.4.1 Global Regenerative Therapies for Osteoarthritis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Regenerative Therapies for Osteoarthritis Revenue in 2021

3.5 Global Regenerative Therapies for Osteoarthritis Key Players Head office and Area Served

3.6 Key Players Regenerative Therapies for Osteoarthritis Product Solution and Service

3.7 Date of Enter into Regenerative Therapies for Osteoarthritis Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Regenerative Therapies for Osteoarthritis Historic Revenue by Type (2017-2022)

4.2 Global Regenerative Therapies for Osteoarthritis Forecasted Revenue by Type (2023-2028)

5.1 Global Regenerative Therapies for Osteoarthritis Historic Market Size by Application (2017-2022)

5.2 Global Regenerative Therapies for Osteoarthritis Forecasted Market Size by Application (2023-2028)

6.1 North America Regenerative Therapies for Osteoarthritis Revenue by Company (2020-2022)

6.2 North America Regenerative Therapies for Osteoarthritis Revenue by Type (2017-2028)

6.3 North America Regenerative Therapies for Osteoarthritis Revenue by Application (2017-2028)

6.4 North America Regenerative Therapies for Osteoarthritis Revenue by Country (2017-2028)

6.4.1 U.S.

6.4.2 Canada

7.1 Europe Regenerative Therapies for Osteoarthritis Revenue by Company (2020-2022)

7.2 Europe Regenerative Therapies for Osteoarthritis Revenue by Type (2017-2028)

7.3 Europe Regenerative Therapies for Osteoarthritis Revenue by Application (2017-2028)

7.4 Europe Regenerative Therapies for Osteoarthritis Revenue by Country (2017-2028)

7.4.1 Germany

7.4.2 France

7.4.3 U.K.

7.4.4 Italy

7.4.5 Russia

8.1 Asia Pacific Regenerative Therapies for Osteoarthritis Revenue by Company (2020-2022)

8.2 Asia Pacific Regenerative Therapies for Osteoarthritis Revenue by Type (2017-2028)

8.3 Asia Pacific Regenerative Therapies for Osteoarthritis Revenue by Application (2017-2028)

8.4 Asia Pacific Regenerative Therapies for Osteoarthritis Revenue by Region (2017-2028)

8.4.1 China

8.4.2 Japan

8.4.3 South Korea

8.4.4 India

8.4.5 Australia

8.4.6 Taiwan

8.4.7 Indonesia

8.4.8 Thailand

8.4.9 Malaysia

8.4.10 Philippines

8.4.11 Vietnam

9.1 Latin America Regenerative Therapies for Osteoarthritis Revenue by Company (2020-2022)

9.2 Latin America Regenerative Therapies for Osteoarthritis Revenue by Type (2017-2028)

9.3 Latin America Regenerative Therapies for Osteoarthritis Revenue by Application (2017-2028)

9.4 Latin America Regenerative Therapies for Osteoarthritis Revenue by Country (2017-2028)

9.4.1 Mexico

9.4.2 Brazil

9.4.3 Argentina

10.1 Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue by Company (2020-2022)

10.2 Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue by Type (2017-2028)

10.3 Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue by Application (2017-2028)

10.4 Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue by Country (2017-2028)

10.4.1 Turkey

10.4.2 Saudi Arabia

10.4.3 U.A.E

11.1 Acelity

11.1.1 Acelity Company Details

11.1.2 Acelity Business Overview

11.1.3 Acelity Regenerative Therapies for Osteoarthritis Products and Services

11.1.4 Acelity Regenerative Therapies for Osteoarthritis Revenue in Regenerative Therapies for Osteoarthritis Business (2017-2022)

11.1.5 Acelity Regenerative Therapies for Osteoarthritis SWOT Analysis

11.1.6 Acelity Recent Developments

11.2 Mesoblast

11.2.1 Mesoblast Company Details

11.2.2 Mesoblast Business Overview

11.2.3 Mesoblast Regenerative Therapies for Osteoarthritis Products and Services

11.2.4 Mesoblast Regenerative Therapies for Osteoarthritis Revenue in Regenerative Therapies for Osteoarthritis Business (2017-2022)

11.2.5 Mesoblast Regenerative Therapies for Osteoarthritis SWOT Analysis

11.2.6 Mesoblast Recent Developments

11.3 Nuo Therapeutics

11.3.1 Nuo Therapeutics Company Details

11.3.2 Nuo Therapeutics Business Overview

11.3.3 Nuo Therapeutics Regenerative Therapies for Osteoarthritis Products and Services

11.3.4 Nuo Therapeutics Regenerative Therapies for Osteoarthritis Revenue in Regenerative Therapies for Osteoarthritis Business (2017-2022)

11.3.5 Nuo Therapeutics Regenerative Therapies for Osteoarthritis SWOT Analysis

11.3.6 Nuo Therapeutics Recent Developments

11.4 Astellas Pharma

11.4.1 Astellas Pharma Company Details

11.4.2 Astellas Pharma Business Overview

11.4.3 Astellas Pharma Regenerative Therapies for Osteoarthritis Products and Services

11.4.4 Astellas Pharma Regenerative Therapies for Osteoarthritis Revenue in Regenerative Therapies for Osteoarthritis Business (2017-2022)

11.4.5 Astellas Pharma Regenerative Therapies for Osteoarthritis SWOT Analysis

11.4.6 Astellas Pharma Recent Developments

11.5 Organovo

11.5.1 Organovo Company Details

11.5.2 Organovo Business Overview

11.5.3 Organovo Regenerative Therapies for Osteoarthritis Products and Services

11.5.4 Organovo Regenerative Therapies for Osteoarthritis Revenue in Regenerative Therapies for Osteoarthritis Business (2017-2022)

11.5.5 Organovo Regenerative Therapies for Osteoarthritis SWOT Analysis

11.5.6 Organovo Recent Developments

11.6 Orgenesis

11.6.1 Orgenesis Company Details

11.6.2 Orgenesis Business Overview

11.6.3 Orgenesis Regenerative Therapies for Osteoarthritis Products and Services

11.6.4 Orgenesis Regenerative Therapies for Osteoarthritis Revenue in Regenerative Therapies for Osteoarthritis Business (2017-2022)

11.6.5 Orgenesis Regenerative Therapies for Osteoarthritis SWOT Analysis

11.6.6 Orgenesis Recent Developments

11.7 Sanofi

11.7.1 Sanofi Company Details

11.7.2 Sanofi Business Overview

11.7.3 Sanofi Regenerative Therapies for Osteoarthritis Products and Services

11.7.4 Sanofi Regenerative Therapies for Osteoarthritis Revenue in Regenerative Therapies for Osteoarthritis Business (2017-2022)

11.7.5 Sanofi Regenerative Therapies for Osteoarthritis SWOT Analysis

11.7.6 Sanofi Recent Developments

11.8 Athersys

11.8.1 Athersys Company Details

11.8.2 Athersys Business Overview

11.8.3 Athersys Regenerative Therapies for Osteoarthritis Products and Services

11.8.4 Athersys Regenerative Therapies for Osteoarthritis Revenue in Regenerative Therapies for Osteoarthritis Business (2017-2022)

11.8.5 Athersys Regenerative Therapies for Osteoarthritis SWOT Analysis

11.8.6 Athersys Recent Developments

11.9 Takeda

11.9.1 Takeda Company Details

11.9.2 Takeda Business Overview

11.9.3 Takeda Regenerative Therapies for Osteoarthritis Products and Services

11.9.4 Takeda Regenerative Therapies for Osteoarthritis Revenue in Regenerative Therapies for Osteoarthritis Business (2017-2022)

11.9.5 Takeda Regenerative Therapies for Osteoarthritis SWOT Analysis

11.9.6 Takeda Recent Developments

11.10 Cytori Therapeutics

11.10.1 Cytori Therapeutics Company Details

11.10.2 Cytori Therapeutics Business Overview

11.10.3 Cytori Therapeutics Regenerative Therapies for Osteoarthritis Products and Services

11.10.4 Cytori Therapeutics Regenerative Therapies for Osteoarthritis Revenue in Regenerative Therapies for Osteoarthritis Business (2017-2022)

11.10.5 Cytori Therapeutics Regenerative Therapies for Osteoarthritis SWOT Analysis

11.10.6 Cytori Therapeutics Recent Developments

12.1 Regenerative Therapies for Osteoarthritis Market Trends

12.2 Regenerative Therapies for Osteoarthritis Market Drivers

12.3 Regenerative Therapies for Osteoarthritis Market Challenges

12.4 Regenerative Therapies for Osteoarthritis Market Restraints

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

List of Tables

    Table 1. Global Regenerative Therapies for Osteoarthritis Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

    Table 2. Key Players of Cell Therapy

    Table 3. Key Players of Tissue Engineering

    Table 4. Key Players of Gene Therapy

    Table 5. Global Regenerative Therapies for Osteoarthritis Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

    Table 6. Global Regenerative Therapies for Osteoarthritis Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028

    Table 7. Global Regenerative Therapies for Osteoarthritis Revenue by Region (2017-2022) & (US$ Million)

    Table 8. Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Region (2017-2022)

    Table 9. Global Regenerative Therapies for Osteoarthritis Revenue by Players (2017-2022) & (US$ Million)

    Table 10. Global Regenerative Therapies for Osteoarthritis Market Share by Players (2017-2022)

    Table 11. Global Top Regenerative Therapies for Osteoarthritis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Therapies for Osteoarthritis as of 2021)

    Table 12. Ranking of Global Top Regenerative Therapies for Osteoarthritis Companies by Revenue (US$ Million) in 2021

    Table 13. Global 5 Largest Players Market Share by Regenerative Therapies for Osteoarthritis Revenue (CR5 and HHI) & (2017-2022)

    Table 14. Key Players Headquarters and Area Served

    Table 15. Key Players Regenerative Therapies for Osteoarthritis Product Solution and Service

    Table 16. Date of Key Manufacturers Enter into Regenerative Therapies for Osteoarthritis Market

    Table 17. Mergers & Acquisitions, Expansion Plans

    Table 18. Global Regenerative Therapies for Osteoarthritis Market Size by Type (2017-2022) & (US$ Million)

    Table 19. Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Type (2017-2022)

    Table 20. Global Regenerative Therapies for Osteoarthritis Forecasted Market Size by Type (2023-2028) & (US$ Million)

    Table 21. Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Type (2023-2028)

    Table 22. Global Regenerative Therapies for Osteoarthritis Market Size by Application (2017-2022) & (US$ Million)

    Table 23. Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Application (2017-2022)

    Table 24. Global Regenerative Therapies for Osteoarthritis Forecasted Market Size by Application (2023-2028) & (US$ Million)

    Table 25. Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Application (2023-2028)

    Table 26. North America Regenerative Therapies for Osteoarthritis Revenue by Company (2020-2022) & (US$ Million)

    Table 27. North America Regenerative Therapies for Osteoarthritis Revenue by Type (2017-2022) & (US$ Million)

    Table 28. North America Regenerative Therapies for Osteoarthritis Revenue by Type (2023-2028) & (US$ Million)

    Table 29. North America Regenerative Therapies for Osteoarthritis Revenue by Application (2017-2022) & (US$ Million)

    Table 30. North America Regenerative Therapies for Osteoarthritis Revenue by Application (2023-2028) & (US$ Million)

    Table 31. North America Regenerative Therapies for Osteoarthritis Revenue by Country (2017-2022) & (US$ Million)

    Table 32. North America Regenerative Therapies for Osteoarthritis Revenue by Country (2023-2028) & (US$ Million)

    Table 33. Europe Regenerative Therapies for Osteoarthritis Revenue by Company (2020-2022) & (US$ Million)

    Table 34. Europe Regenerative Therapies for Osteoarthritis Revenue by Type (2017-2022) & (US$ Million)

    Table 35. Europe Regenerative Therapies for Osteoarthritis Revenue by Type (2023-2028) & (US$ Million)

    Table 36. Europe Regenerative Therapies for Osteoarthritis Revenue by Application (2017-2022) & (US$ Million)

    Table 37. Europe Regenerative Therapies for Osteoarthritis Revenue by Application (2023-2028) & (US$ Million)

    Table 38. Europe Regenerative Therapies for Osteoarthritis Revenue by Country (2017-2022) & (US$ Million)

    Table 39. Europe Regenerative Therapies for Osteoarthritis Revenue by Country (2023-2028) & (US$ Million)

    Table 40. Asia Pacific Regenerative Therapies for Osteoarthritis Revenue by Company (2020-2022) & (US$ Million)

    Table 41. Asia Pacific Regenerative Therapies for Osteoarthritis Revenue by Type (2017-2022) & (US$ Million)

    Table 42. Asia Pacific Regenerative Therapies for Osteoarthritis Revenue by Type (2023-2028) & (US$ Million)

    Table 43. Asia Pacific Regenerative Therapies for Osteoarthritis Revenue by Application (2017-2022) & (US$ Million)

    Table 44. Asia Pacific Regenerative Therapies for Osteoarthritis Revenue by Application (2023-2028) & (US$ Million)

    Table 45. Asia Pacific Regenerative Therapies for Osteoarthritis Revenue by Region (2017-2022) & (US$ Million)

    Table 46. Asia Pacific Regenerative Therapies for Osteoarthritis Revenue by Region (2023-2028) & (US$ Million)

    Table 47. Latin America Regenerative Therapies for Osteoarthritis Revenue by Company (2020-2022) & (US$ Million)

    Table 48. Latin America Regenerative Therapies for Osteoarthritis Revenue by Type (2017-2022) & (US$ Million)

    Table 49. Latin America Regenerative Therapies for Osteoarthritis Revenue by Type (2023-2028) & (US$ Million)

    Table 50. Latin America Regenerative Therapies for Osteoarthritis Revenue by Application (2017-2022) & (US$ Million)

    Table 51. Latin America Regenerative Therapies for Osteoarthritis Revenue by Application (2023-2028) & (US$ Million)

    Table 52. Latin America Regenerative Therapies for Osteoarthritis Revenue by Country (2017-2022) & (US$ Million)

    Table 53. Latin America Regenerative Therapies for Osteoarthritis Revenue by Country (2023-2028) & (US$ Million)

    Table 54. Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue by Company (2020-2022) & (US$ Million)

    Table 55. Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue by Type (2017-2022) & (US$ Million)

    Table 56. Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue by Type (2023-2028) & (US$ Million)

    Table 57. Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue by Application (2017-2022) & (US$ Million)

    Table 58. Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue by Application (2023-2028) & (US$ Million)

    Table 59. Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue by Country (2017-2022) & (US$ Million)

    Table 60. Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue by Country (2023-2028) & (US$ Million)

    Table 61. Acelity Company Details

    Table 62. Acelity Business Overview

    Table 63. Acelity Regenerative Therapies for Osteoarthritis Product and Services

    Table 64. Acelity Regenerative Therapies for Osteoarthritis Revenue in Regenerative Therapies for Osteoarthritis Business (2017-2022) & (US$ Million)

    Table 65. Acelity Regenerative Therapies for Osteoarthritis SWOT Analysis

    Table 66. Acelity Recent Developments

    Table 67. Mesoblast Company Details

    Table 68. Mesoblast Business Overview

    Table 69. Mesoblast Regenerative Therapies for Osteoarthritis Product and Services

    Table 70. Mesoblast Regenerative Therapies for Osteoarthritis Revenue in Regenerative Therapies for Osteoarthritis Business (2017-2022) & (US$ Million)

    Table 71. Mesoblast Regenerative Therapies for Osteoarthritis SWOT Analysis

    Table 72. Mesoblast Recent Developments

    Table 73. Nuo Therapeutics Company Details

    Table 74. Nuo Therapeutics Business Overview

    Table 75. Nuo Therapeutics Regenerative Therapies for Osteoarthritis Product and Services

    Table 76. Nuo Therapeutics Regenerative Therapies for Osteoarthritis Revenue in Regenerative Therapies for Osteoarthritis Business (2017-2022) & (US$ Million)

    Table 77. Nuo Therapeutics Regenerative Therapies for Osteoarthritis SWOT Analysis

    Table 78. Nuo Therapeutics Recent Developments

    Table 79. Astellas Pharma Company Details

    Table 80. Astellas Pharma Business Overview

    Table 81. Astellas Pharma Regenerative Therapies for Osteoarthritis Product and Services

    Table 82. Astellas Pharma Regenerative Therapies for Osteoarthritis Revenue in Regenerative Therapies for Osteoarthritis Business (2017-2022) & (US$ Million)

    Table 83. Astellas Pharma Regenerative Therapies for Osteoarthritis SWOT Analysis

    Table 84. Astellas Pharma Recent Developments

    Table 85. Organovo Company Details

    Table 86. Organovo Business Overview

    Table 87. Organovo Regenerative Therapies for Osteoarthritis Product and Services

    Table 88. Organovo Regenerative Therapies for Osteoarthritis Revenue in Regenerative Therapies for Osteoarthritis Business (2017-2022) & (US$ Million)

    Table 89. Organovo Regenerative Therapies for Osteoarthritis SWOT Analysis

    Table 90. Organovo Recent Developments

    Table 91. Orgenesis Company Details

    Table 92. Orgenesis Business Overview

    Table 93. Orgenesis Regenerative Therapies for Osteoarthritis Product and Services

    Table 94. Orgenesis Regenerative Therapies for Osteoarthritis Revenue in Regenerative Therapies for Osteoarthritis Business (2017-2022) & (US$ Million)

    Table 95. Orgenesis Regenerative Therapies for Osteoarthritis SWOT Analysis

    Table 96. Orgenesis Recent Developments

    Table 97. Sanofi Company Details

    Table 98. Sanofi Business Overview

    Table 99. Sanofi Regenerative Therapies for Osteoarthritis Product and Services

    Table 100. Sanofi Regenerative Therapies for Osteoarthritis Revenue in Regenerative Therapies for Osteoarthritis Business (2017-2022) & (US$ Million)

    Table 101. Sanofi Regenerative Therapies for Osteoarthritis SWOT Analysis

    Table 102. Sanofi Recent Developments

    Table 103. Athersys Company Details

    Table 104. Athersys Business Overview

    Table 105. Athersys Regenerative Therapies for Osteoarthritis Product and Services

    Table 106. Athersys Regenerative Therapies for Osteoarthritis Revenue in Regenerative Therapies for Osteoarthritis Business (2017-2022) & (US$ Million)

    Table 107. Athersys Regenerative Therapies for Osteoarthritis SWOT Analysis

    Table 108. Athersys Recent Developments

    Table 109. Takeda Company Details

    Table 110. Takeda Business Overview

    Table 111. Takeda Regenerative Therapies for Osteoarthritis Product and Services

    Table 112. Takeda Regenerative Therapies for Osteoarthritis Revenue in Regenerative Therapies for Osteoarthritis Business (2017-2022) & (US$ Million)

    Table 113. Takeda Regenerative Therapies for Osteoarthritis SWOT Analysis

    Table 114. Takeda Recent Developments

    Table 115. Cytori Therapeutics Company Details

    Table 116. Cytori Therapeutics Business Overview

    Table 117. Cytori Therapeutics Regenerative Therapies for Osteoarthritis Product and Services

    Table 118. Cytori Therapeutics Regenerative Therapies for Osteoarthritis Revenue in Regenerative Therapies for Osteoarthritis Business (2017-2022) & (US$ Million)

    Table 119. Cytori Therapeutics Regenerative Therapies for Osteoarthritis SWOT Analysis

    Table 120. Cytori Therapeutics Recent Developments

    Table 121. Regenerative Therapies for Osteoarthritis Market Trends

    Table 122. Regenerative Therapies for Osteoarthritis Market Drivers

    Table 123. Regenerative Therapies for Osteoarthritis Market Challenges

    Table 124. Regenerative Therapies for Osteoarthritis Market Restraints

    Table 125. Research Programs/Design for This Report

    Table 126. Key Data Information from Secondary Sources

    Table 127. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Regenerative Therapies for Osteoarthritis Sales Market Share by Type: 2021 VS 2028

    Figure 2. Cell Therapy Features

    Figure 3. Tissue Engineering Features

    Figure 4. Gene Therapy Features

    Figure 5. Global Regenerative Therapies for Osteoarthritis Sales Market Share by Application: 2021 VS 2028

    Figure 6. Hospitals Case Studies

    Figure 7. Ambulatory Surgical Centers Case Studies

    Figure 8. Orthopaedic Clinics Case Studies

    Figure 9. Research Institutes Case Studies

    Figure 10. Regenerative Therapies for Osteoarthritis Report Years Considered

    Figure 11. Global Regenerative Therapies for Osteoarthritis Revenue, (US$ Million), 2017 VS 2021 VS 2028

    Figure 12. Global Regenerative Therapies for Osteoarthritis Market Size 2017-2028 (US$ Million)

    Figure 13. Global Regenerative Therapies for Osteoarthritis Market Size Market Share by Region: 2021 VS 2028

    Figure 14. Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Region in 2017 VS 2022

    Figure 15. Global Top 10 Regenerative Therapies for Osteoarthritis Countries Ranking by Market Size (US$ Million) in 2021

    Figure 16. Global Regenerative Therapies for Osteoarthritis Market Share by Players in 2021

    Figure 17. Global Top Regenerative Therapies for Osteoarthritis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Therapies for Osteoarthritis as of 2021)

    Figure 18. The Top 10 and 5 Players Market Share by Regenerative Therapies for Osteoarthritis Revenue in 2021

    Figure 19. North America Regenerative Therapies for Osteoarthritis Revenue Market Share by Company in 2021

    Figure 20. North America Regenerative Therapies for Osteoarthritis Revenue Market Share by Type (2017-2028)

    Figure 21. North America Regenerative Therapies for Osteoarthritis Revenue Market Share by Application (2017-2028)

    Figure 22. North America Regenerative Therapies for Osteoarthritis Revenue Share by Country (2017-2028)

    Figure 23. U.S. Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 24. Canada Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 25. Europe Regenerative Therapies for Osteoarthritis Revenue Market Share by Company in 2021

    Figure 26. Europe Regenerative Therapies for Osteoarthritis Revenue Market Share by Type (2017-2028)

    Figure 27. Europe Regenerative Therapies for Osteoarthritis Revenue Market Share by Application (2017-2028)

    Figure 28. Europe Regenerative Therapies for Osteoarthritis Revenue Share by Country (2017-2028)

    Figure 29. Germany Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 30. France Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 31. U.K. Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 32. Italy Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 33. Russia Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 34. Asia Pacific Regenerative Therapies for Osteoarthritis Revenue Market Share by Company in 2021

    Figure 35. Asia Pacific Regenerative Therapies for Osteoarthritis Revenue Market Share by Type (2017-2028)

    Figure 36. Asia Pacific Regenerative Therapies for Osteoarthritis Revenue Market Share by Application (2017-2028)

    Figure 37. Asia Pacific Regenerative Therapies for Osteoarthritis Revenue Share by Region (2017-2028)

    Figure 38. China Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 39. Japan Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 40. South Korea Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 41. India Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 42. Australia Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 43. Taiwan Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 44. Indonesia Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 45. Thailand Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 46. Malaysia Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 47. Philippines Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 48. Vietnam Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 49. Latin America Regenerative Therapies for Osteoarthritis Revenue Market Share by Company in 2021

    Figure 50. Latin America Regenerative Therapies for Osteoarthritis Revenue Market Share by Type (2017-2028)

    Figure 51. Latin America Regenerative Therapies for Osteoarthritis Revenue Market Share by Application (2017-2028)

    Figure 52. Latin America Regenerative Therapies for Osteoarthritis Revenue Share by Country (2017-2028)

    Figure 53. Mexico Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 54. Brazil Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 55. Argentina Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 56. Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue Market Share by Company in 2021

    Figure 57. Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue Market Share by Type (2017-2028)

    Figure 58. Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue Market Share by Application (2017-2028)

    Figure 59. Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue Share by Country (2017-2028)

    Figure 60. Turkey Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 61. Saudi Arabia Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 62. U.A.E Regenerative Therapies for Osteoarthritis Revenue (2017-2028) & (US$ Million)

    Figure 63. Acelity Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2017-2022)

    Figure 64. Mesoblast Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2017-2022)

    Figure 65. Nuo Therapeutics Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2017-2022)

    Figure 66. Astellas Pharma Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2017-2022)

    Figure 67. Organovo Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2017-2022)

    Figure 68. Orgenesis Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2017-2022)

    Figure 69. Sanofi Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2017-2022)

    Figure 70. Athersys Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2017-2022)

    Figure 71. Takeda Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2017-2022)

    Figure 72. Cytori Therapeutics Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2017-2022)

    Figure 73. Bottom-up and Top-down Approaches for This Report

    Figure 74. Data Triangulation

    Figure 75. Key Executives Interviewed